The Marcus Corporation (MCS) president receives 16,400-share stock grant

Rhea-AI Filing Summary

The Marcus Corporation president of Marcus Theatres, Mark A. Gramz, reported an acquisition of 16,400 shares of common stock on February 11, 2026 as a restricted stock grant at a price of $0 per share. Following this award, he directly holds 52,161 common shares.

The restricted stock granted on February 11, 2026 vests over time, with 50% vesting after the second anniversary of the grant date and 100% after the third anniversary. The filing also lists multiple previously granted stock options with various exercise prices and expiration dates, all held directly.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gramz Mark A

(Last) (First) (Middle)

THE MARCUS CORPORATION

111 E KILBOURN AVENUE, SUITE 1200

(Street)

MILWAUKEE WI 53202

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MARCUS CORP [ MCS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Pres., Marcus Theatres

3. Date of Earliest Transaction (Month/Day/Year)
02/11/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/11/2026		A(1)		16,400	A	$0	52,161	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$31.2							(2)	02/28/2027	Common Stock	3,500		3,500	D
Stock Option (Right to Buy)	$27							(3)	02/27/2028	Common Stock	3,500		3,500	D
Stock Option (Right to Buy)	$41.9							(3)	02/26/2029	Common Stock	3,500		3,500	D
Stock Option (Right to Buy)	$28.88							(3)	02/25/2030	Common Stock	3,500		3,500	D
Stock Option (Right to Buy)	$12.71							(3)	05/08/2030	Common Stock	1,750		1,750	D
Stock Option (Right to Buy)	$21.84							(3)	03/09/2031	Common Stock	4,200		4,200	D
Stock Option (Right to Buy)	$17.04							(3)	03/08/2032	Common Stock	3,500		3,500	D
Stock Option (Right to Buy)	$15.99							(3)	03/07/2033	Common Stock	27,500		27,500	D

Explanation of Responses:

1. Restricted stock granted February 11, 2026 vests and becomes exercisable as follows: 50% after 2nd anniversary of date of grant and 100% after 3rd anniversary of date of grant.

2. The options originally granted vest as follows: 40% after 2nd anniversary of the date of grant; 60% after 3rd anniversary; 80% after 4th anniversary; and 100% after 5 years.

3. The options originally granted vest as follows: 50% after 2nd anniversary of the date of grant; 75% after 3rd anniversary; and 100% after 4 years.

	/s/ Steven R. Barth, Attorney-in-Fact for Mark A. Gramz	02/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did MCS executive Mark A. Gramz report?

Mark A. Gramz reported receiving a grant of 16,400 shares of The Marcus Corporation common stock on February 11, 2026. The shares were acquired at a price of $0 per share as a restricted stock award, increasing his direct holdings to 52,161 shares.

How does the new restricted stock grant for MCS affect Mark A. Gramz’s holdings?

After the February 11, 2026 restricted stock grant of 16,400 shares, Mark A. Gramz directly holds 52,161 shares of The Marcus Corporation common stock. This reflects the addition of the new award to his prior beneficial ownership reported in the filing.

What is the vesting schedule of Mark A. Gramz’s 2026 restricted stock grant at MCS?

The restricted stock granted to Mark A. Gramz on February 11, 2026 vests in stages: 50% after the second anniversary of the grant date and 100% after the third anniversary. This schedule ties full ownership of the shares to continued service over time.

Were any stock options for The Marcus Corporation exercised or sold in this Form 4?

The Form 4 lists several stock option holdings for The Marcus Corporation common stock with different exercise prices and expiration dates. However, the transactions are shown as holdings, and the filing does not report any new option exercises or sales in these entries.

What role does Mark A. Gramz hold at The Marcus Corporation?

Mark A. Gramz is reported as an officer of The Marcus Corporation, serving as President of Marcus Theatres. His relationship to the issuer is disclosed in the filing, which also shows he is not a director and not a ten percent owner.

At what price was the MCS restricted stock granted to Mark A. Gramz?

The 16,400 restricted shares of The Marcus Corporation common stock granted to Mark A. Gramz on February 11, 2026 were recorded at a price of $0 per share. This reflects a compensatory equity award rather than an open-market purchase.